Topic

Harmful rules in the Trans-Pacific Partnership (TPP) trade deal will mean people in developing countries will have less access to lifesaving medicines.

More >

MSF testifies in Congress on India's right to keep lifesaving medicines affordable.

More >

In this blog post from BMJ Group Blogs, lawyer and India manager of MSF's Access Campaign Leena Menghaney discusses the two legal battles that are taking center stage in the struggle over India's medicines patent law.

More >

MSF helped organize a fashion show for women living with HIV to show what is possible when treatment is made available and to alert the public to the tragic lack of access to treatment in the country.

More >

MSF's appeal to Novartis to drop its case against India continues as the pharmaceutical company's day in court draws near.

More >

On Monday, December 19, Johnson & Johnson is expected to announce whether it intends to license its patents on three lifesaving HIV/AIDS drugs to the Medicines Patent Pool, a mechanism designed to lower prices of HIV medicines and increase access to them for people in the developing world.

More >

MSF International President Dr. Unni Karunakara discusses the Global Fund to Fight AIDS, TB, and Malaria's decision not to accept grant applications this year to support treatment programs due to a catastrophic drop in donor funding. 

More >

Health facilities in the Gaza Strip are facing a serious shortage of drugs and medical supplies.

More >

Every day, Senzo wakes up and walks to catch a bus to the clinic for his daily injection. The injection is part of the complicated two-year-long treatment for his drug-resistant form of TB.

More >

The Meningitis Vaccine Project was launched in 2001 with the main goal of creating an affordable vaccine that would respond to a specific meningitis strain that plagues Africa each year.

More >

Pages